MX386374B - Composiciones farmacéuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten. - Google Patents

Composiciones farmacéuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten.

Info

Publication number
MX386374B
MX386374B MX2017004317A MX2017004317A MX386374B MX 386374 B MX386374 B MX 386374B MX 2017004317 A MX2017004317 A MX 2017004317A MX 2017004317 A MX2017004317 A MX 2017004317A MX 386374 B MX386374 B MX 386374B
Authority
MX
Mexico
Prior art keywords
satiety
need
subjects
pharmaceutical
nutritional compositions
Prior art date
Application number
MX2017004317A
Other languages
English (en)
Spanish (es)
Other versions
MX2017004317A (es
Inventor
Gregory Lambert
Jonathan Breton
Pierre Dechelotte
Serguei Fetissov
Original Assignee
Inst Nat Sante Rech Med
Univ Rouen Centre Hospitalier
Targedys
Univ Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Univ Rouen Centre Hospitalier, Targedys, Univ Rouen filed Critical Inst Nat Sante Rech Med
Publication of MX2017004317A publication Critical patent/MX2017004317A/es
Publication of MX386374B publication Critical patent/MX386374B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2017004317A 2014-10-02 2015-06-05 Composiciones farmacéuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten. MX386374B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306552 2014-10-02
PCT/IB2015/001126 WO2016059455A1 (en) 2014-10-02 2015-06-05 Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof

Publications (2)

Publication Number Publication Date
MX2017004317A MX2017004317A (es) 2017-10-04
MX386374B true MX386374B (es) 2025-03-18

Family

ID=51799054

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2017004317A MX386374B (es) 2014-10-02 2015-06-05 Composiciones farmacéuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten.
MX2017015702A MX2017015702A (es) 2014-10-02 2016-04-05 Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesitan.
MX2018012056A MX2018012056A (es) 2014-10-02 2017-04-05 Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2017015702A MX2017015702A (es) 2014-10-02 2016-04-05 Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesitan.
MX2018012056A MX2018012056A (es) 2014-10-02 2017-04-05 Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad.

Country Status (14)

Country Link
US (3) US20170252399A1 (cg-RX-API-DMAC10.html)
EP (2) EP3200814B1 (cg-RX-API-DMAC10.html)
JP (3) JP6855372B2 (cg-RX-API-DMAC10.html)
KR (3) KR20170066543A (cg-RX-API-DMAC10.html)
CN (2) CN106999545B (cg-RX-API-DMAC10.html)
AU (2) AU2015332168B2 (cg-RX-API-DMAC10.html)
BR (2) BR112017006770A2 (cg-RX-API-DMAC10.html)
CA (1) CA2962907C (cg-RX-API-DMAC10.html)
ES (3) ES2828952T3 (cg-RX-API-DMAC10.html)
IL (1) IL256136B (cg-RX-API-DMAC10.html)
MX (3) MX386374B (cg-RX-API-DMAC10.html)
PT (1) PT3439684T (cg-RX-API-DMAC10.html)
RU (3) RU2717018C2 (cg-RX-API-DMAC10.html)
WO (2) WO2016059455A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729770B2 (en) 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов
EP3384922A1 (en) * 2017-04-03 2018-10-10 Targedys Brassicaceae protein extract and uses thereof
FR3076981B1 (fr) * 2018-01-19 2020-01-31 Zhivko Radev Methode de fabrication de produits alimentaires a base de yaourt
CN108715851B (zh) * 2018-04-28 2023-05-16 中山大学 一种斜带石斑鱼摄食调控相关基因AgRP1及其应用
EP3886882A1 (en) 2018-11-28 2021-10-06 Targedys Hafnia alvei formulations
JP2022510891A (ja) * 2018-11-28 2022-01-28 タージェディズ 無機成分を含むハフニア・アルベイ（Ｈａｆｎｉａ ａｌｖｅｉ）組成物
MY189523A (en) * 2019-05-22 2022-02-16 Mizkan Holdings Co Ltd Solid composition containing insoluble dietary fiber and method for manufacturing the same
KR102973977B1 (ko) * 2021-11-26 2026-06-09 충남대학교산학협력단 알파-멜라노사이트 자극 호르몬의 펩티드 변이체 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003359A1 (en) * 1995-07-07 1997-01-30 Oravax, Inc. Helicobacter clpb
WO1999048372A1 (en) 1998-03-23 1999-09-30 General Mills, Inc. Encapsulation of components into edible products
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
MX2008009726A (es) * 2006-01-27 2009-03-05 Danisco Uso de microorganismos probioticos para el tratamiento y prevencion de la obesidad y trastornos relacionados.
JP2009534034A (ja) * 2006-04-19 2009-09-24 ノヴォ ノルディスク アクティーゼルスカブ 原核微生物におけるｏ−グリコシル化治療用タンパク質の発現
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
EP2053122A1 (en) * 2007-10-23 2009-04-29 Nestec S.A. Stress tolerant bifidobacteria
IN2014DN07752A (cg-RX-API-DMAC10.html) * 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
US10729770B2 (en) * 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
CN105979957A (zh) * 2013-12-05 2016-09-28 国家医疗保健研究所 细菌通过模拟α-MSH的CLPB蛋白对宿主进食与情绪的影响
PL3076985T3 (pl) * 2013-12-05 2024-12-16 Institut National De La Santé Et De La Recherche Médicale (Inserm) Kompozycja zawierająca probiotyki z nadekspresją białka clpb do zastosowania w leczeniu otyłości
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов

Also Published As

Publication number Publication date
MX2017004317A (es) 2017-10-04
RU2017110516A3 (cg-RX-API-DMAC10.html) 2018-11-05
MX2017015702A (es) 2018-12-11
RU2717018C2 (ru) 2020-03-17
JP6876627B2 (ja) 2021-06-02
IL256136A (en) 2018-02-28
RU2017142932A (ru) 2019-07-11
WO2017174658A1 (en) 2017-10-12
EP3769777B9 (en) 2022-10-26
EP3769777A1 (en) 2021-01-27
CA3020050A1 (en) 2017-10-12
MX2018012056A (es) 2019-03-28
JP2019513832A (ja) 2019-05-30
AU2015332168B2 (en) 2021-02-25
RU2017110516A (ru) 2018-11-05
US11389489B2 (en) 2022-07-19
RU2018138995A3 (cg-RX-API-DMAC10.html) 2020-11-09
US10888592B2 (en) 2021-01-12
IL256136B (en) 2021-02-28
RU2766585C2 (ru) 2022-03-15
EP3200814A1 (en) 2017-08-09
RU2018138995A (ru) 2020-05-12
ES2928379T3 (es) 2022-11-17
JP2018521982A (ja) 2018-08-09
EP3769777B1 (en) 2022-07-27
AU2016272850A1 (en) 2017-12-21
CN106999545A (zh) 2017-08-01
KR20170066543A (ko) 2017-06-14
US20170252399A1 (en) 2017-09-07
BR112017006770A2 (pt) 2018-11-06
AU2015332168A1 (en) 2017-04-20
ES2808939T3 (es) 2021-03-02
ES2828952T3 (es) 2021-05-28
KR102472169B1 (ko) 2022-11-29
WO2016059455A1 (en) 2016-04-21
US20200297783A1 (en) 2020-09-24
HK1252744A1 (zh) 2019-05-31
CN106999545B (zh) 2021-09-21
JP6855372B2 (ja) 2021-04-07
JP2018503597A (ja) 2018-02-08
RU2017142932A3 (cg-RX-API-DMAC10.html) 2019-07-17
PT3439684T (pt) 2020-07-31
KR20180011841A (ko) 2018-02-02
CN109310736B (zh) 2022-09-13
US20190142876A1 (en) 2019-05-16
KR20190010543A (ko) 2019-01-30
BR112017026241A2 (pt) 2018-09-11
CA2962907C (en) 2022-06-07
JP6987122B2 (ja) 2022-01-05
CA2962907A1 (en) 2016-04-21
CN109310736A (zh) 2019-02-05
EP3200814B1 (en) 2020-09-23

Similar Documents

Publication Publication Date Title
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
MX2017004317A (es) Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten.
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
DK3559022T3 (da) Virulenssvækket bakteriebaseret proteinlevering
MX2017008698A (es) Composiciones multi-suplementos.
BR112016026378A2 (pt) formulações e métodos para tratamento com queratina
MX2018002990A (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
GB2541571A (en) Pharmaceutical compositions
MX2015015518A (es) Metodos y composiciones para el tratamiento del cancer.
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
MX2017014390A (es) Piroglutamato de vortioxetina.
TR201908639T4 (tr) Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler.
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
MX2017000472A (es) Combinacion de extracto de raiz de valeriana y aceite de lavanda para su utilizacion en el tratamiento de trastornos del sueño.
BR112015016033A2 (pt) composições e métodos para tratamento de infecções por bactérias
MX392976B (es) Composiciones que comprenden cepas bacterianas.
FR3019746B1 (fr) Diffuseur de substances, notamment de parfum, d'huiles essentielles
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento
EA201691335A1 (ru) Гексагидрофуропирролы в качестве ингибиторов pde1
PL3102212T3 (pl) Inhibitor białka przenoszącego estry cholesterolu (CETP) i kompozycje farmaceutyczne zawierające taki inhibitor do stosowania w leczeniu chorób sercowo-naczyniowych lub zapobieganiu im.
BR112017013158A2 (pt) formulações de cálcio e fosfato para inflamação bucal.